KorthJWildeBDolffS, et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol. 2020;128:104437. doi:10.1016/j.jcv.2020.104437
2.
DimeglioCHerinFMiedougéM, et al. Screening for SARS-CoV-2 antibodies among healthcare workers in a university hospital in southern France. J Infect. 2021;82:e29-e32. doi:10.1016/j.jinf.2020.09.035
3.
HunterBRDbeiboLWeaverCS, et al. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure. Infect Control Hosp Epidemiol. 2020;41:1441-1442. doi:10.1017/ice
YounasAWaheedSKhawajaSImamMBorhanyMShamsiT.Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan. Transfus Apher Sci. 2020;59:102923. doi:10.1016/j.transci.2020.102923
7.
Garcia-BasteiroALMoncunillGTortajadaM, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020;11:3500. doi:10.1038/s41467-020-17318-x
8.
AnandSMontez-RathMHanJ, et al. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet. 2020;396:1335-1344.
9.
ChenYTongXWangJ, et al. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients. J Infect. 2020;81:420-426. doi:10.1016/j.jinf.2020.05.067
10.
HoulihanCFVoraNByrneT, et al. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020;396:e6-e7. doi:10.1016/S0140-6736(20)31484-7